MedTrace Logo

Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions.

NCT01409551 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-11-17

No results posted yet for this study

Summary

Aim of this study is to compare two methods of pleurodesis for refractory malignant pleural effusions, in terms of safety and efficacy.

Conditions

  • Safety of Intervention
  • Efficacy of Intervention
  • Cost Effectiveness

Interventions

PROCEDURE

VATS hyperthermic chemoperfusion

VATS, adhesiolysis, hyperthermic chemoperfusion (with a pump machine)

PROCEDURE

Bedside talc slurry pleurodesis

Bedside tube thoracostomy under local anesthesia. Bedside talc slurry pleurodesis.

Sponsors & Collaborators

  • Theagenio Cancer Hospital

    lead OTHER_GOV

Principal Investigators

  • Nikolaos Barbetakis, MD, PhD · Theagenio Cancer Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01409551 on ClinicalTrials.gov